The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Denosumab and pembrolizumab in clear cell renal carcinoma (KEYPAD): A phase II trial (ANZUP1601).
 
Craig Gedye
Consulting or Advisory Role - Abbvie (Inst); Bristol-Myers Squibb (Inst); Ipsen (Inst); Merck Sharp & Dohme (Inst); Novotech; Pfizer (Inst)
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Merck Sharp & Dohme (Inst)
Travel, Accommodations, Expenses - Astellas Pharma (Inst); Astellas Pharma (Inst); Merck Sharp & Dohme (Inst)
 
Abhishek Jagdish Joshi
Honoraria - AstraZeneca; Ipsen; Pfizer
Travel, Accommodations, Expenses - Bristol-Myers Squibb/Pfizer; Merck Sharp & Dohme; Novartis/Ipsen; Roche
 
Alison Yan Zhang
Honoraria - Astellas Pharma; Astellas Pharma (Inst); AstraZeneca; AstraZeneca (Inst); Mundipharma; Pfizer (Inst)
Consulting or Advisory Role - Merck Sharp & Dohme
Travel, Accommodations, Expenses - Astellas Pharma; Ipsen
 
Andrew James Martin
No Relationships to Disclose
 
Anthony M. Joshua
Consulting or Advisory Role - AstraZeneca (Inst); Ipsen (Inst); IQvia (Inst); Janssen Oncology (Inst); Neoleukin Therapeutics (Inst); Novartis (Inst); Noxopharm (Inst); Pfizer (Inst); Sanofi (Inst)
Research Funding - AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Corvus Pharmaceuticals (Inst); Janssen Oncology (Inst); Lilly (Inst); Lilly (Inst); Macrogenics (Inst); Mayne Pharma (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Roche/Genentech (Inst)
 
Carole A. Harris
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); Merck; Pfizer
 
Craig Underhill
Research Funding - Bristol-Myers Squibb (Inst)
 
David William Pook
Honoraria - Astellas Pharma; Ipsen; Novartis
Consulting or Advisory Role - Bristol-Myers Squibb; Bristol-Myers Squibb; Merck Sharp & Dohme; Merck Sharp & Dohme (Inst); Pfizer; Pfizer (Inst)
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Medivation (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Roche (Inst); SymVivo (Inst)
Travel, Accommodations, Expenses - Amgen; Astellas Pharma; Bristol-Myers Squibb; Pfizer
 
Guy C. Toner
Consulting or Advisory Role - Amgen (Inst); Bayer (Inst)
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Medivation (Inst); Medivation (Inst)
 
Ganessan Kichenadasse
No Relationships to Disclose
 
Jane Yeojeong So
Travel, Accommodations, Expenses - Roche
 
Jeffrey C. Goh
Stock and Other Ownership Interests - Immutep
Honoraria - Ipsen
Consulting or Advisory Role - AstraZeneca; Tesaro
Speakers' Bureau - AstraZeneca; Ipsen; Janssen; Mundipharma; Novartis
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca
 
Michelle Frances Morris
Travel, Accommodations, Expenses - Amgen
 
Nicola Jane Lawrence
No Relationships to Disclose
 
Tom Ferguson
Research Funding - AstraZeneca (Inst); Janssen (Inst); MSD (Inst)
Travel, Accommodations, Expenses - MSD; Roche
 
Paul Austin Vasey
No Relationships to Disclose
 
Prashanth Prithviraj
No Relationships to Disclose
 
Shalini Subramaniam
No Relationships to Disclose
 
Martin R. Stockler
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bionomics (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Medivation (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst); Tilray (Inst)
Travel, Accommodations, Expenses - Medivation/Pfizer
 
Ian D. Davis
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Exelixis (Inst); Ipsen (Inst); Janssen Oncology (Inst); Medivation (Inst); Movember Foundation (Inst); MSD Oncology (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Patents, Royalties, Other Intellectual Property - International Patent Application No: PCT /US2004/032147 (NY-ESO-1) through Ludwig Institute for Cancer Research.